PolarityBio to Present Phase 3 SkinTE Data at SAWC Fall 2026
SALT LAKE CITY — September 29, 2026 PolarityBio announced that results from its pivotal Phase 3 COVER DFUS II...
chronic wounds
Advertisement
Flen Health and AGC Biologics Advance Enzyme Wound Therapy
Heidelberg, Germany, September 24, 2026 Flen Health has selected AGC Biologics as its contract development and manufacturing organization (CDMO)...
Applied Biologics Completes CAMPX Patient Follow-Up
SCOTTSDALE, Ariz. — September 22, 2026 Applied Biologics announced Last Patient, Last Visit (LPLV) in the 222-patient CAMPX multicenter...
PolarityBio Gains FDA Priority Review for SkinTE in DFUs
SALT LAKE CITY, Utah — September 15, 2026 PolarityBio announced that the U.S. Food and Drug Administration (FDA) has...
Cirrus Expands Ocular Immunology Through SERI Partnership
Cambridge, Massachusetts & Singapore, August 4, 2026 Cirrus Therapeutics has strengthened its position as an emerging ocular immunology biotechnology...
Advertisements
AsymBio Secures $184 Million to Expand Global CDMO Growth
Shanghai, China, August 4, 2026 AsymBio, the biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem...
BioLab Publishes Membrane Wrap Study for Pressure Ulcers
Phoenix, Arizona, August 3, 2026 BioLab Holdings, Inc. has announced the publication of a peer-reviewed real-world evidence (RWE) study...
Organogenesis Publishes Positive Affinity Trial Results for Venous Leg Ulcers
CANTON, Mass., July 27, 2026 Organogenesis Holdings Inc. announced the publication of peer-reviewed clinical trial results demonstrating the effectiveness...
Merakris Therapeutics Wins NIH Funding for MTX-001
RESEARCH TRIANGLE PARK, N.C., July 21, 2026 Merakris Therapeutics announced that it has received a Direct-to-Phase II Small Business...
FibroBiologics Doses First Patients in Phase 1/2 Trial of CYWC628 for Diabetic Foot Ulcers
HOUSTON, June 16, 2026 FibroBiologics announced that the first patients have been dosed in its ongoing Phase 1/2 clinical...
Advertisement
